AVITA Medical, Inc. (RCEL)

US — Healthcare Sector
Peers: TBIO  CLPT  SGHT  TMCI  RXST  AXGN  LUNG  OFIX  VREX  APYX  SIBN  IRMD  TELA  CVRX  NPCE  TMDX  DCTH 

Automate Your Wheel Strategy on RCEL

With Tiblio's Option Bot, you can configure your own wheel strategy including RCEL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol RCEL
  • Rev/Share 2.4574
  • Book/Share 0.1721
  • PB 32.661
  • Debt/Equity 10.2212
  • CurrentRatio 2.8277
  • ROIC -0.937

 

  • MktCap 148562772.0
  • FreeCF/Share -2.2287
  • PFCF -2.5495
  • PE -2.376
  • Debt/Assets 0.5769
  • DivYield 0
  • ROE -3.379

 

  • Rating D+
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation RCEL D. Boral Capital -- Buy -- $25 Dec. 24, 2024

News

AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript
RCEL
Published: May 08, 2025 by: Seeking Alpha
Sentiment: Neutral

AVITA Medical, Inc. (NASDAQ:RCEL ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director, Investor Relations Jim Corbett - Chief Executive Officer David O'Toole - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Chris Kallos - MST Access Operator Good day, and thank you for standing by. Welcome to AVITA Medical First Quarter 2025 Earnings Conference Call.

Read More
image for news AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference
RCEL
Published: February 26, 2025 by: GlobeNewsWire
Sentiment: Neutral

AVITA Medical announced that Jim Corbett, CEO, will present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025, at 11:50 a.m. Eastern Time.

Read More
image for news AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference
After Sales Rebound In January, AVITA Is Set Up For A Monster Year
RCEL
Published: February 18, 2025 by: Seeking Alpha
Sentiment: Positive

After Sales Rebound In January, AVITA Is Set Up For A Monster Year

Read More
image for news After Sales Rebound In January, AVITA Is Set Up For A Monster Year
AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript
RCEL
Published: February 13, 2025 by: Seeking Alpha
Sentiment: Neutral

AVITA Medical, Inc. (NASDAQ:RCEL ) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Officer David O'Toole - Chief Financial Officer Conference Call Participants Matthew Park - Cantor Fitzgerald Ryan Zimmerman - BTIG Brooks O'Neil - Lake Street Capital Markets Joshua Jennings - TD Cowen Operator Good day, and thank you for standing by. Welcome to the AVITA Medical Fourth Quarter 2024 Earnings Conference Call.

Read More
image for news AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
RCEL
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral

VALENCIA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for the fourth quarter and full year ended December 31, 2024.

Read More
image for news AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results

About AVITA Medical, Inc. (RCEL)

  • IPO Date 2012-05-14
  • Website https://www.avitamedical.com
  • Industry Medical - Devices
  • CEO Mr. James M. Corbett
  • Employees 260

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.